ESR1 and breast cancer: Therefore, for assessing whether KD of these genes isspecifically effective for sensitizing onlyMCF-7 cells to SI-12 treatment, we performed siRNA perturbation experiments in four additional BC cell lines (three ER+: BT474, ZR-75-1 and T47D, and one TNBC: MDAMB-231).